CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4 Advances in Coronary No-Reflow Phenomenon-a Contemporary Review Impact of Coronary Lesion Complexity in Percutaneous Coronary Intervention: One-Year Outcomes From the Large, Multicentre e-Ultimaster Registry Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC Guidelines An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial

Clinical Trial2013 Apr 16;61(15):1596-600.

JOURNAL:J Am Coll Cardiol. Article Link

Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study

Weisz G, Metzger DC, Caputo RP et al. Keywords: angioplasty; robotic-enhanced PCI; stent

Full Text PDF